Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Islets of Langerhans Transplantation | 15 | 2012 | 748 | 3.180 |
Why?
|
| Islets of Langerhans | 14 | 2012 | 1349 | 2.100 |
Why?
|
| Diabetes Mellitus, Experimental | 10 | 2011 | 1121 | 1.490 |
Why?
|
| Neovascularization, Physiologic | 10 | 2012 | 1369 | 1.410 |
Why?
|
| Nerve Growth Factor | 4 | 2011 | 157 | 1.140 |
Why?
|
| Diabetes Mellitus, Type 1 | 13 | 2012 | 3439 | 1.110 |
Why?
|
| Mice, Inbred BALB C | 15 | 2012 | 6241 | 0.640 |
Why?
|
| Portal Vein | 4 | 2011 | 432 | 0.520 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 3 | 2011 | 144 | 0.480 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 4 | 2011 | 621 | 0.410 |
Why?
|
| Bone Marrow Cells | 2 | 2010 | 2415 | 0.400 |
Why?
|
| Bone Marrow Transplantation | 2 | 2010 | 2702 | 0.390 |
Why?
|
| Hypoglycemic Agents | 6 | 2011 | 3111 | 0.380 |
Why?
|
| Insulin | 10 | 2011 | 6606 | 0.350 |
Why?
|
| Liver Regeneration | 1 | 2012 | 214 | 0.350 |
Why?
|
| Sulfonylurea Compounds | 2 | 2011 | 220 | 0.350 |
Why?
|
| Glucose Tolerance Test | 6 | 2012 | 1181 | 0.340 |
Why?
|
| Angiogenic Proteins | 1 | 2010 | 101 | 0.340 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2010 | 166 | 0.330 |
Why?
|
| Hepatic Veins | 1 | 2009 | 112 | 0.320 |
Why?
|
| Pancreas Transplantation | 1 | 2010 | 198 | 0.320 |
Why?
|
| Graft Survival | 5 | 2011 | 3890 | 0.320 |
Why?
|
| Blood Glucose | 13 | 2011 | 6429 | 0.310 |
Why?
|
| Heart Transplantation | 3 | 2006 | 3291 | 0.270 |
Why?
|
| Blood Glucose Self-Monitoring | 2 | 2005 | 475 | 0.230 |
Why?
|
| Hypoglycemia | 4 | 2005 | 894 | 0.230 |
Why?
|
| Autoantibodies | 2 | 2003 | 2131 | 0.220 |
Why?
|
| Home Infusion Therapy | 1 | 2003 | 18 | 0.210 |
Why?
|
| Pancreas | 1 | 2010 | 1703 | 0.210 |
Why?
|
| Hyperglycemia | 3 | 2006 | 1389 | 0.200 |
Why?
|
| Growth | 1 | 2004 | 366 | 0.200 |
Why?
|
| Immunosuppressive Agents | 4 | 2007 | 4213 | 0.190 |
Why?
|
| Mice | 15 | 2012 | 82051 | 0.180 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2010 | 36840 | 0.180 |
Why?
|
| Ischemia | 1 | 2009 | 1900 | 0.170 |
Why?
|
| Diabetic Ketoacidosis | 2 | 2003 | 255 | 0.170 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 2012 | 3520 | 0.170 |
Why?
|
| Septum Pellucidum | 1 | 2000 | 55 | 0.170 |
Why?
|
| Venous Thrombosis | 1 | 2009 | 1317 | 0.170 |
Why?
|
| Embolization, Therapeutic | 1 | 2009 | 1435 | 0.160 |
Why?
|
| Contrast Media | 2 | 2009 | 5337 | 0.160 |
Why?
|
| Sertoli Cells | 1 | 1998 | 50 | 0.160 |
Why?
|
| Transplantation, Isogeneic | 2 | 2009 | 249 | 0.160 |
Why?
|
| Pituitary Hormones | 1 | 2000 | 182 | 0.160 |
Why?
|
| Autoantigens | 1 | 2003 | 893 | 0.160 |
Why?
|
| Human Growth Hormone | 2 | 2004 | 648 | 0.160 |
Why?
|
| Diabetes Mellitus | 3 | 2007 | 5887 | 0.150 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 1999 | 268 | 0.150 |
Why?
|
| HLA Antigens | 1 | 2003 | 1333 | 0.140 |
Why?
|
| Vascular Diseases | 1 | 2006 | 1162 | 0.140 |
Why?
|
| Facial Asymmetry | 1 | 1998 | 173 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 1998 | 348 | 0.140 |
Why?
|
| Pituitary Gland | 1 | 2000 | 634 | 0.140 |
Why?
|
| Seasons | 1 | 2003 | 1526 | 0.140 |
Why?
|
| Liver | 2 | 2009 | 7575 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1998 | 640 | 0.130 |
Why?
|
| Animals | 16 | 2012 | 169424 | 0.130 |
Why?
|
| Mutation, Missense | 2 | 2011 | 2590 | 0.130 |
Why?
|
| Optic Nerve | 1 | 2000 | 572 | 0.130 |
Why?
|
| Leptin | 3 | 2004 | 1598 | 0.130 |
Why?
|
| Liver Transplantation | 1 | 2007 | 2399 | 0.130 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 1997 | 437 | 0.120 |
Why?
|
| Abnormalities, Multiple | 2 | 2000 | 1424 | 0.120 |
Why?
|
| Child | 17 | 2007 | 80856 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2004 | 12242 | 0.110 |
Why?
|
| Chromosome Deletion | 1 | 1998 | 1390 | 0.110 |
Why?
|
| Gadolinium | 2 | 2009 | 965 | 0.110 |
Why?
|
| Autoimmunity | 1 | 2001 | 1361 | 0.110 |
Why?
|
| Body Height | 1 | 1999 | 1568 | 0.110 |
Why?
|
| Air Pollution | 1 | 2006 | 2364 | 0.100 |
Why?
|
| Cyclosporine | 2 | 2006 | 781 | 0.100 |
Why?
|
| Child, Preschool | 9 | 2007 | 42620 | 0.100 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2012 | 221 | 0.100 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1999 | 1943 | 0.090 |
Why?
|
| Receptors, Drug | 1 | 2011 | 157 | 0.090 |
Why?
|
| Chromosome Aberrations | 1 | 1998 | 1781 | 0.090 |
Why?
|
| Glutamate Decarboxylase | 2 | 2003 | 239 | 0.090 |
Why?
|
| Environmental Exposure | 1 | 2006 | 4533 | 0.090 |
Why?
|
| Infant, Newborn | 6 | 2011 | 26394 | 0.090 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2012 | 270 | 0.090 |
Why?
|
| Female | 22 | 2011 | 396926 | 0.090 |
Why?
|
| Radioimmunoassay | 2 | 2001 | 862 | 0.090 |
Why?
|
| Male | 21 | 2012 | 364761 | 0.080 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2010 | 616 | 0.080 |
Why?
|
| Fetus | 1 | 1997 | 1883 | 0.080 |
Why?
|
| Streptozocin | 1 | 2009 | 195 | 0.080 |
Why?
|
| Portal System | 1 | 2009 | 49 | 0.080 |
Why?
|
| Body Mass Index | 5 | 2007 | 13030 | 0.080 |
Why?
|
| Time Factors | 5 | 2010 | 40271 | 0.080 |
Why?
|
| Adolescent | 10 | 2007 | 89163 | 0.080 |
Why?
|
| Hepatectomy | 1 | 2012 | 588 | 0.080 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2011 | 568 | 0.070 |
Why?
|
| Antigens, CD34 | 1 | 2010 | 656 | 0.070 |
Why?
|
| Area Under Curve | 1 | 2012 | 1640 | 0.070 |
Why?
|
| Infant | 5 | 2011 | 36496 | 0.070 |
Why?
|
| Necrosis | 1 | 2011 | 1622 | 0.070 |
Why?
|
| Subrenal Capsule Assay | 1 | 2006 | 27 | 0.070 |
Why?
|
| Hypothyroidism | 2 | 2004 | 670 | 0.070 |
Why?
|
| Immunohistochemistry | 3 | 2008 | 11139 | 0.070 |
Why?
|
| Birth Weight | 2 | 2006 | 2117 | 0.070 |
Why?
|
| von Willebrand Factor | 1 | 2010 | 679 | 0.070 |
Why?
|
| Cell Survival | 2 | 2006 | 5800 | 0.060 |
Why?
|
| Radionuclide Imaging | 1 | 2009 | 1998 | 0.060 |
Why?
|
| Gadolinium DTPA | 1 | 2008 | 823 | 0.060 |
Why?
|
| Sulfates | 1 | 2006 | 379 | 0.060 |
Why?
|
| Infusions, Intravenous | 1 | 2009 | 2228 | 0.060 |
Why?
|
| Amino Acid Substitution | 2 | 2006 | 1742 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 1999 | 5808 | 0.060 |
Why?
|
| HLA-DR Antigens | 1 | 2006 | 606 | 0.060 |
Why?
|
| Cell Hypoxia | 1 | 2006 | 661 | 0.060 |
Why?
|
| Tacrolimus | 1 | 2007 | 750 | 0.060 |
Why?
|
| Postoperative Period | 1 | 2009 | 1833 | 0.060 |
Why?
|
| Insulin Antibodies | 1 | 2003 | 28 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2007 | 12096 | 0.050 |
Why?
|
| Cytomegalovirus | 1 | 2007 | 755 | 0.050 |
Why?
|
| Treatment Failure | 1 | 2009 | 2655 | 0.050 |
Why?
|
| Thyroglobulin | 1 | 2003 | 111 | 0.050 |
Why?
|
| Humans | 23 | 2011 | 768369 | 0.050 |
Why?
|
| Syndrome | 2 | 2000 | 3278 | 0.050 |
Why?
|
| Insulin, Long-Acting | 1 | 2003 | 59 | 0.050 |
Why?
|
| Lipoproteins, LDL | 1 | 2006 | 644 | 0.050 |
Why?
|
| Models, Statistical | 2 | 2008 | 5103 | 0.050 |
Why?
|
| Ozone | 1 | 2006 | 490 | 0.050 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2004 | 294 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2009 | 19035 | 0.050 |
Why?
|
| Autopsy | 1 | 2006 | 1013 | 0.050 |
Why?
|
| Genes, MHC Class II | 1 | 2003 | 433 | 0.050 |
Why?
|
| Infusion Pumps | 1 | 2003 | 163 | 0.050 |
Why?
|
| Azathioprine | 1 | 2003 | 354 | 0.050 |
Why?
|
| California | 1 | 2006 | 1444 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 1999 | 9623 | 0.050 |
Why?
|
| Monitoring, Ambulatory | 1 | 2005 | 357 | 0.050 |
Why?
|
| Antilymphocyte Serum | 1 | 2003 | 491 | 0.050 |
Why?
|
| Apoptosis | 2 | 2009 | 9526 | 0.050 |
Why?
|
| Hydrocortisone | 2 | 1999 | 1836 | 0.050 |
Why?
|
| Iodide Peroxidase | 1 | 2003 | 295 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2010 | 2431 | 0.040 |
Why?
|
| Administration, Cutaneous | 1 | 2003 | 716 | 0.040 |
Why?
|
| Angiography | 1 | 2006 | 1597 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2010 | 2858 | 0.040 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2006 | 828 | 0.040 |
Why?
|
| Sampling Studies | 1 | 2001 | 617 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 1 | 1 | 1999 | 27 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2010 | 2994 | 0.040 |
Why?
|
| Transcription Factors | 1 | 1999 | 12176 | 0.040 |
Why?
|
| Immune Sera | 1 | 1999 | 605 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 1999 | 93 | 0.040 |
Why?
|
| Embryonic and Fetal Development | 1 | 2000 | 420 | 0.040 |
Why?
|
| Image Enhancement | 1 | 2009 | 2895 | 0.040 |
Why?
|
| Electrolytes | 1 | 1999 | 278 | 0.040 |
Why?
|
| Iron | 1 | 2007 | 1813 | 0.040 |
Why?
|
| Sex Factors | 2 | 2003 | 10647 | 0.040 |
Why?
|
| Reference Values | 1 | 2006 | 4941 | 0.040 |
Why?
|
| Educational Status | 1 | 2006 | 2519 | 0.040 |
Why?
|
| Mexican Americans | 1 | 1999 | 164 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 1999 | 174 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2005 | 1669 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 1999 | 415 | 0.040 |
Why?
|
| Karyotyping | 1 | 1999 | 1173 | 0.040 |
Why?
|
| Fetal Organ Maturity | 1 | 1997 | 83 | 0.040 |
Why?
|
| Glucose Transporter Type 2 | 1 | 1997 | 61 | 0.040 |
Why?
|
| Ear, External | 1 | 1998 | 165 | 0.040 |
Why?
|
| Cholesterol | 1 | 2006 | 2910 | 0.030 |
Why?
|
| Retrospective Studies | 5 | 2003 | 81835 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2006 | 6353 | 0.030 |
Why?
|
| Thyroxine | 1 | 1999 | 666 | 0.030 |
Why?
|
| Fluid Therapy | 1 | 1999 | 585 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2006 | 4202 | 0.030 |
Why?
|
| Family | 1 | 2006 | 3208 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2001 | 13025 | 0.030 |
Why?
|
| Lipids | 1 | 2006 | 3346 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2004 | 2170 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2008 | 3543 | 0.030 |
Why?
|
| Glucose | 1 | 2006 | 4355 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2006 | 9687 | 0.030 |
Why?
|
| Kidney | 1 | 2009 | 7064 | 0.030 |
Why?
|
| Growth Disorders | 1 | 1998 | 635 | 0.030 |
Why?
|
| Weight Gain | 1 | 2003 | 2357 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2003 | 2696 | 0.030 |
Why?
|
| Cleft Lip | 1 | 1998 | 513 | 0.030 |
Why?
|
| Adult | 5 | 2011 | 223528 | 0.030 |
Why?
|
| Cleft Palate | 1 | 1998 | 598 | 0.020 |
Why?
|
| Body Weight | 1 | 2003 | 4630 | 0.020 |
Why?
|
| Vision Disorders | 1 | 1999 | 1092 | 0.020 |
Why?
|
| Kinetics | 1 | 1999 | 6347 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 1997 | 2696 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2006 | 12561 | 0.020 |
Why?
|
| Logistic Models | 1 | 2006 | 13323 | 0.020 |
Why?
|
| Patient Selection | 1 | 2003 | 4266 | 0.020 |
Why?
|
| Hearing Loss | 1 | 1998 | 786 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2004 | 3974 | 0.020 |
Why?
|
| Developmental Disabilities | 1 | 1998 | 1516 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1999 | 6087 | 0.020 |
Why?
|
| Quality of Life | 1 | 2011 | 13497 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2003 | 41782 | 0.020 |
Why?
|
| Substance-Related Disorders | 1 | 2006 | 4453 | 0.020 |
Why?
|
| Risk Factors | 2 | 2009 | 74915 | 0.020 |
Why?
|
| Genotype | 1 | 2003 | 13045 | 0.020 |
Why?
|
| Gestational Age | 1 | 1997 | 3615 | 0.020 |
Why?
|
| Incidence | 1 | 2006 | 21552 | 0.020 |
Why?
|
| Pedigree | 2 | 2004 | 4545 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1997 | 8201 | 0.020 |
Why?
|
| Research Design | 1 | 2001 | 6217 | 0.020 |
Why?
|
| Pituitary Diseases | 1 | 2004 | 136 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2001 | 20232 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2003 | 24310 | 0.010 |
Why?
|
| Obesity | 1 | 2004 | 13065 | 0.010 |
Why?
|
| Mutation | 1 | 2006 | 30235 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2004 | 943 | 0.010 |
Why?
|
| Rats | 1 | 1997 | 23839 | 0.010 |
Why?
|
| Calibration | 1 | 2003 | 823 | 0.010 |
Why?
|
| Hormones | 1 | 2004 | 870 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2006 | 65408 | 0.010 |
Why?
|
| Pregnancy | 1 | 1997 | 30179 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 2004 | 2260 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 14725 | 0.000 |
Why?
|
Concepts
(216)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(2)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_